Skip to main content
ABCL filings

Corporate insider profile

Michael R Hayden Filing Activity

Latest reported as Corporate insider of AbCellera Biologics Inc. (ABCL).

Purchase filings
2
Reported companies
2
Net open-market value
$1,539,733
Latest transaction
Aug 12, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 12, 2026AbCellera Biologics Inc. (ABCL)Corporate insiderOpen Market Purchase46,387$10.37$481,033
Jul 31, 2026IONIS PHARMACEUTICALS INC (IONS)Corporate insiderOpen Market Purchase20,000$52.94$1,058,700